GCP
GBIO

GSA Capital Partners’s Generation Bio GBIO Stock Holding History

GSA Capital Partners’s Portfolio GBIO Stock Details GBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,424
Closed -$261K – 1772
2024
Q1 		$261K Sell
6,424
-6,583
-51% -$155K 0.02% 1293
2023
Q4 		$215K Buy
13,007
+8,775
+207% +$153K 0.02% 1287
2023
Q3 		$160K Buy
+4,232
New +$200K 0.01% 1327
2023
Q2 		– Sell
-13,115
Closed -$564K – 1644
2023
Q1 		$564K Buy
13,115
+4,500
+52% +$218K 0.06% 632
2022
Q4 		$339K Buy
8,615
+320
+4% +$16.8K 0.04% 851
2022
Q3 		$440K Buy
8,295
+6,449
+349% +$403K 0.06% 669
2022
Q2 		$121K Buy
+1,846
New +$121K 0.02% 1188
2022
Q1 		– Sell
-1,774
Closed -$126K – 1546
2021
Q4 		$126K Buy
+1,774
New +$310K 0.02% 1295

Other funds holding GBIO

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

GSA Capital Partners's GBIO Position: Q2 2024 in Review

GSA Capital Partners sold out of Generation Bio (GBIO) in Q2 2024, closing a stake of 6,424 shares — an estimated $261K sold.

GSA Capital Partners first reported a position in GBIO in Q4 2021 and held it in 8 quarters. The position peaked at $564K in Q1 2023. 77 funds tracked by Wall St. Rank hold GBIO as of Q2 2024.

  • GSA Capital Partners reported no remaining Generation Bio position as of Q2 2024 after selling out during the quarter.
  • GSA Capital Partners sold 6,424 Generation Bio shares in Q2 2024, an estimated $261K.
  • GSA Capital Partners first reported a position in Generation Bio in Q4 2021 and held it in 8 quarters.
  • GSA Capital Partners's Generation Bio position peaked at $564K in Q1 2023.
  • 77 funds tracked by Wall St. Rank held Generation Bio as of Q2 2024.

Based on GSA Capital Partners's 13F filing for Q2 2024, filed 15 Aug 2024.